Evidence-Based Medicine Guidelines
Interferon beta for secondary progressive multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Interferon Beta for Secondary Progressive Multiple Sclerosis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457582/all/Interferon_beta_for_secondary_progressive_multiple_sclerosis.
Interferon beta for secondary progressive multiple sclerosis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/457582/all/Interferon_beta_for_secondary_progressive_multiple_sclerosis. Accessed October 15, 2024.
Interferon beta for secondary progressive multiple sclerosis. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457582/all/Interferon_beta_for_secondary_progressive_multiple_sclerosis
Interferon Beta for Secondary Progressive Multiple Sclerosis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457582/all/Interferon_beta_for_secondary_progressive_multiple_sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Interferon beta for secondary progressive multiple sclerosis
ID - 457582
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457582/all/Interferon_beta_for_secondary_progressive_multiple_sclerosis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
